Form 4: CapsoVision Director Acquires Shares via RSU Vesting

Sentiment:

Statement of Changes in Beneficial Ownership


CapsoVision, Inc. reports that Director Tsai Chen Lung acquired 2,022 shares of common stock through the vesting of Restricted Stock Units.

Summary

  • Director Tsai Chen Lung acquired 2,022 shares of CapsoVision, Inc. common stock on June 30, 2026.
  • The acquisition occurred through the vesting of Restricted Stock Units (RSUs) granted on March 19, 2026.
  • The fair market value of the shares at the time of the RSU grant was $6.18 per share.
  • The RSU grant vests in two tranches: 50% on June 30 and 50% on December 31 of the applicable year.
  • This report reflects the vesting of one-half of the original RSU grant.
  • Following this transaction, Tsai Chen Lung beneficially owns 4,929 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity compensation event for a director rather than a significant financial or strategic development.

Positives

  • Director Tsai Chen Lung's beneficial ownership of CapsoVision, Inc. common stock has increased.
  • The vesting of RSUs indicates continued equity incentive for key personnel.
  • The transaction reflects a standard equity compensation practice.

Future Outlook

The filing indicates that the second tranche of the RSU grant, representing 50% of the original award, is set to vest on December 31 of the applicable year.

Industry Context

StockSavvy.ai notes that the use of Restricted Stock Units (RSUs) for director compensation is a common practice across the technology and growth sectors, aligning management and board interests with shareholder value.

Stakeholder Impact

  • Shareholders: The transaction reflects standard executive compensation, which can influence share dilution but also aligns management incentives.
  • Management/Directors: The vesting of RSUs provides direct financial benefit and reinforces commitment to the company.

Next Steps

  • Vesting of the remaining 50% of the RSU grant on December 31 of the applicable year.

Key Dates

DateDescription
03/19/2026Date of RSU grant
06/30/2026Date of earliest transaction and first tranche vesting of RSUs
12/31/2026Second tranche vesting date for RSUs
07/01/2026Date of filing signature

Keywords

CapsoVision, Inc., Form 4, Tsai Chen Lung, Director, Restricted Stock Units, RSU Vesting, Common Stock, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.